A daring new therapy delivery method offers hope for Duchenne muscular dystrophy patients.

Published Date: 03 May 2023

Doug Millay is a Ph. D. has devoted his professional life to elucidating the most basic mechanisms underlying the development of skeletal muscle. He works in the Division of Molecular Cardiovascular Biology at Cincinnati Children's. He already has.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Advances in "next generation" photoactive cancer therapy

2.

Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL

3.

The American College of Physicians updated its recommendations for colorectal cancer screening.

4.

Optimizing Sequencing of BCMA-Directed Therapies in Myeloma

5.

According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot